Reply to: “Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients”

Yael Renert-Yuval, Emma Guttman-Yassky

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)2269-2270
Number of pages2
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume77
Issue number7
DOIs
StatePublished - Jul 2022

Cite this